Piper Sandler analyst Allison Bratzel maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of ...

Accenture (NYSE:ACN – Free Report) had its price objective decreased by Piper Sandler from $429.00 to $396.00 in a research ...

Huntington Bancshares (NASDAQ:HBAN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $22.00 ...

Wall Street brokerages on Monday started coverage on SailPoint Technologies with broadly bullish views, but some analysts ...

On Monday, Piper Sandler, a well-known financial ... each setting distinct ratings and price targets for the company. Morgan Stanley initiated coverage with an Equalweight rating and a price ...

On Wednesday, Piper Sandler analyst Dave Westenberg upgraded ... while maintaining Underweight and Underperform ratings. Morgan Stanley also adjusted its price target to $16, citing softer volumes ...

Sarepta Therapeutics said on Tuesday a young man has died due to acute liver failure after treatment with its gene therapy for a rare muscular dystrophy.

Looking for shelter as the market sinks? Here's where to put your money.

In terms of liquidity and interest, the mean open interest for First Solar options trades today is 851.88 with a total volume of 597.00.

According to data compiled by S&P Global Market Intelligence, Oatly (NASDAQ: OTLY) shares lost more than 11% of their value across this week. That wasn't entirely unexpected, as two analysts cut their ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...